Zobrazeno 41 - 50
of 675
pro vyhledávání: '"Stephen G. Swisher"'
Autor:
Steven H. Lin, John V. Heymach, Ritsuko Komaki, Ignacio I. Wistuba, Junya Fujimoto, Stephen G. Swisher, Jing Wang, Brian P. Hobbs, Nan Li, Wen Jiang, Rui Ye, Weiye Deng, Jun Yan, Uma Giri, Jayanthi Gudikote, Yifan Wang
Supplementary Table S1. List of all primers and oligos used in this study. Supplementary Table S2. Subcellular staining locations of 12 candidate marker proteins in tumor microarray. Supplementary Table S3. Staining results for 17 candidate marker pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3187ae0f7790b6db868eaefa0b6a02c3
https://doi.org/10.1158/1078-0432.22467236
https://doi.org/10.1158/1078-0432.22467236
Autor:
Waun K. Hong, J. Jack Lee, Wayne L. Hofstetter, Stephen G. Swisher, Ignacio I. Wistuba, David C. Rice, Humam Kadara, Luisa M. Solis, Carmen Behrens, Ping Yuan, Diane D. Liu, Edward S. Kim, Kathryn A. Gold
PDF file - 84K, Kaplan Meier curves for RFS and OS by marker group for patients with stage I NSCLC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f606d2fae9b289a6f1d27c51339d7ed
https://doi.org/10.1158/1078-0432.22452372.v1
https://doi.org/10.1158/1078-0432.22452372.v1
Autor:
John V. Heymach, William N. William, Ignacio I. Wistuba, Don L. Gibbons, Stephen G. Swisher, J. Jack Lee, Ara A. Vaporciyan, Cesar Moran, Annikka Weissferdt, Carmen Behrens, David C. Rice, Reza J. Mehran, Mara B. Antonoff, George R. Simon, Frank E. Mott, Charles Lu, Vincent K. Lam, Anne S. Tsao, Frank V. Fossella, Jianjun Zhang, Myrna C.B. Godoy, Mei Jiang, Edwin R. Parra, Neda Kalhor, Heather Y. Lin, Boris Sepesi, Tina Cascone
Supplementary Figure 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9f623efbb0736d57d0a96e764ed44f
https://doi.org/10.1158/1078-0432.22475063
https://doi.org/10.1158/1078-0432.22475063
Autor:
Humam Kadara, Paul Scheet, Ignacio I. Wistuba, Erik A. Ehli, Avrum E. Spira, Jerry Fowler, Jing Wang, Stephen G. Swisher, Randa El-Zein, Reza Mehran, Junya Fujimoto, Cesar Moran, Neda Kalhor, Carmen Behrens, Jing Huang, Gareth Davies, Zachary Weber, Chi-Wan Chow, Wei Lu, Li Shen, Suk-Young Yoo, Lili Huang, Li Xu, Melinda Garcia, Selina Vattathil, Wenhua Lang, Yasminka Jakubek
Supplementary information including supplementary methods, supplementary tables and figures as well as supplementary figure legends. Supplementary Figure 1. HapLOH results for matched normal large airway and NSCLC tumor from case 18 Supplementary Fig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03b27d7f4e9c780f53e7cf131596724f
https://doi.org/10.1158/0008-5472.22411944.v1
https://doi.org/10.1158/0008-5472.22411944.v1
Autor:
John V. Heymach, Jhanelle E. Gray, Vassiliki A. Papadimitrakopoulou, Jianjun Zhang, Bonnie S. Glisson, William N. William, J. Jack Lee, Stephen G. Swisher, Jack A. Roth, Jeff Lewis, Lara C. Lacerda, Yasir Elamin, Huiying Sun, Ming Tang, Waree Rinsurongkawong, Emily Roarty, Katherine L. Lovinger, J. Kevin Hicks, Theresa Boyle, Jacqulyne Robichaux, Monique B. Nilsson, Marcelo V. Negrao, Sonam Puri, Xiuning Le
Purpose:Osimertinib was initially approved for T790M-positive non–small cell lung cancer (NSCLC) and, more recently, for first-line treatment of EGFR-mutant NSCLC. However, resistance mechanisms to osimertinib have been incompletely described.Exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f6415d99f91051ff0ed5d92fa50b9be
https://doi.org/10.1158/1078-0432.c.6526994.v1
https://doi.org/10.1158/1078-0432.c.6526994.v1
Autor:
Bingliang Fang, John V. Heymach, Stephen G. Swisher, Jack A. Roth, John D. Minna, Luc Girard, Vanessa B. Jensen, Qing H. Meng, Jing Wang, Pan Tong, Lei Li, Shuhong Wu, Xingxiang Pu, Ran Zhang, Li Wang, Xiaoshan Zhang, Xiang Yan
Glutathione (GSH)/GSH reductase (GSR) and thioredoxin/thioredoxin reductase (TXNRD) are two major compensating thiol-dependent antioxidant pathways that maintain protein dithiol/disulfide balance. We hypothesized that functional deficiency in one of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca86d33988e70661f39b520c6653ca46
https://doi.org/10.1158/0008-5472.c.6510836.v1
https://doi.org/10.1158/0008-5472.c.6510836.v1
Autor:
Waun K. Hong, J. Jack Lee, Wayne L. Hofstetter, Stephen G. Swisher, Ignacio I. Wistuba, David C. Rice, Humam Kadara, Luisa M. Solis, Carmen Behrens, Ping Yuan, Diane D. Liu, Edward S. Kim, Kathryn A. Gold
Purpose: Patients with resected non–small cell lung cancer (NSCLC) are at risk for recurrence of disease, but we do not have tools to predict which patients are at highest risk. We set out to create a risk model incorporating both clinical data and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ee833079b214c832da9b09b519f6613
https://doi.org/10.1158/1078-0432.c.6522459
https://doi.org/10.1158/1078-0432.c.6522459
Autor:
Waun K. Hong, J. Jack Lee, Wayne L. Hofstetter, Stephen G. Swisher, Ignacio I. Wistuba, David C. Rice, Humam Kadara, Luisa M. Solis, Carmen Behrens, Ping Yuan, Diane D. Liu, Edward S. Kim, Kathryn A. Gold
PDF file - 68K, Multicovariate Cox model for RFS in stage I NSCLC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f20a2fb051f26c49a81da6c53c60172
https://doi.org/10.1158/1078-0432.22452366.v1
https://doi.org/10.1158/1078-0432.22452366.v1
Autor:
John V. Heymach, William N. William, Ignacio I. Wistuba, Don L. Gibbons, Stephen G. Swisher, J. Jack Lee, Ara A. Vaporciyan, Cesar Moran, Annikka Weissferdt, Carmen Behrens, David C. Rice, Reza J. Mehran, Mara B. Antonoff, George R. Simon, Frank E. Mott, Charles Lu, Vincent K. Lam, Anne S. Tsao, Frank V. Fossella, Jianjun Zhang, Myrna C.B. Godoy, Mei Jiang, Edwin R. Parra, Neda Kalhor, Heather Y. Lin, Boris Sepesi, Tina Cascone
Supplementary Figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::351ce51381d1cdb60dd4d97889369677
https://doi.org/10.1158/1078-0432.22475066.v1
https://doi.org/10.1158/1078-0432.22475066.v1
Autor:
Humam Kadara, Ignacio I. Wistuba, Mariano Provencio, Luisa M. Solis, Tina Cascone, Boris Sepesi, J. Jack Lee, Don L. Gibbons, John V. Heymach, Stephen G. Swisher, Junya Fujimoto, Cara Haymaker, Edwin R. Parra, Apar Pataer, Ximing Tang, Wei Lu, Carmen Behrens, Katsuhiro Yoshimura, Beatriz Sanchez-Espiridon, Neus Bota-Rabassedas, Alberto Cruz-Bermúdez, Raquel Laza-Briviesca, Jiexin Zhang, Pedro Rocha
Purpose:Our understanding of the immunopathology of resectable non–small cell lung cancer (NSCLC) is still limited. Here, we explore immune programs that inform of tumor immunity and response to neoadjuvant chemotherapy and chemoimmunotherapy in lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::758466c45170c4b13db8daef12f552c4
https://doi.org/10.1158/1078-0432.c.6532419.v1
https://doi.org/10.1158/1078-0432.c.6532419.v1